ONDANSETRON ACCORD ondansetron 8mg/4mL (as hydrochloride dihydrate) injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

ondansetron accord ondansetron 8mg/4ml (as hydrochloride dihydrate) injection ampoule

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.98 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; sodium citrate dihydrate; citric acid monohydrate - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

ONDANSETRON ACCORD ondansetron 4mg/2mL (as hydrochloride dihydrate) injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

ondansetron accord ondansetron 4mg/2ml (as hydrochloride dihydrate) injection ampoule

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.99 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; citric acid monohydrate; sodium citrate dihydrate; hydrochloric acid; sodium chloride - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

ZOTREN 8 ondansetron (as hydrochloride dihydrate) 8mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

zotren 8 ondansetron (as hydrochloride dihydrate) 8mg tablet blister pack

arrotex pharmaceuticals pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.972 mg (equivalent: ondansetron, qty 8 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; pregelatinised maize starch; lactose; magnesium stearate; titanium dioxide; hypromellose; triacetin; iron oxide yellow - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

ZOTREN 4 ondansetron (as hydrochloride dihydrate) 4mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

zotren 4 ondansetron (as hydrochloride dihydrate) 4mg tablet blister pack

arrotex pharmaceuticals pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.986 mg (equivalent: ondansetron, qty 4 mg) - tablet, film coated - excipient ingredients: pregelatinised maize starch; triacetin; titanium dioxide; microcrystalline cellulose; hypromellose; lactose; magnesium stearate - ondansetron is indicated for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.

ONDANSETRON ACCORD ondansetron (as hydrochloride dihydrate) 8 mg/4 mL solution for injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

ondansetron accord ondansetron (as hydrochloride dihydrate) 8 mg/4 ml solution for injection pre-filled syringe

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 9.98 mg (equivalent: ondansetron, qty 8 mg) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride; sodium citrate dihydrate; citric acid monohydrate - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

ONDANSETRON ACCORD ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

ondansetron accord ondansetron (as hydrochloride dihydrate) 4 mg/2 ml solution for injection pre-filled syringe

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.99 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; citric acid monohydrate; sodium citrate dihydrate; hydrochloric acid; sodium chloride - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

ONDANSETRON-Baxter ondansetron (as hydrochloride) 4 mg/2 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

ondansetron-baxter ondansetron (as hydrochloride) 4 mg/2 ml solution for injection ampoule

baxter healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.98 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: sodium citrate dihydrate; sodium chloride; citric acid monohydrate; water for injections - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. prevention and treatment of post-operative nausea and vomiting.

ONDANSETRON SZ ondansetron (as hydrochloride dihydrate) 8 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

ondansetron sz ondansetron (as hydrochloride dihydrate) 8 mg film-coated tablet blister pack

dr reddys laboratories australia pty ltd - ondansetron hydrochloride dihydrate, quantity: 10 mg (equivalent: ondansetron, qty 8 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; lactose monohydrate; pregelatinised maize starch; sodium starch glycollate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 400 - prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy.